Emmanuella Faith Amoako

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Emmanuella Faith Amoako

Sep 23, 2024, 14:26 | Blog,Opinion

Delighted to announce our participation in the Progress study - Oxford Nanopore Technologies

Emmanuella-Faith Amoako, Paediatric Haematologist Oncologist, Director of Clinical Affairs Yemaachi Biotech, shared a post on…

Sep 19, 2024, 08:29 | Blog

Oxford Nanopore Technologies: Delighted to announce our participation in the PROGRESS study

Emmanuella-Faith Amoako, Paediatric Oncology Fellow at Korle-Bu Teaching Hospital, shared a post by Oxford Nanopore…

Feb 26, 2024, 17:58 | Blog

Sylvan Baca: Wonderful to chat with Emmanuella Faith Amoako about cancer genomics in Africa

Sylvan Baca, Assistant Professor at Harvard Medical School and the Dana-Farber Cancer Institute, recently posted…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023